New guidelines issued for arthritis drugs

BMJ 2001; 323 doi: (Published 04 August 2001) Cite this as: BMJ 2001;323:251
  1. Helen Barratt
  1. BMJ

    Patients with osteoarthritis or rheumatoid arthritis who are at high risk of gastrointestinal complications should have access to COX 2 (cyclo-oxygenase-2) selective inhibitors, according to new guidelines from the National Institute for Clinical Excellence.

    The institute's long awaited report, which applies to patients in England and Wales, classified high risk patients as those …

    View Full Text

    Log in

    Log in through your institution


    * For online subscription